Zobrazeno 1 - 4
of 4
pro vyhledávání: '"EG Medvedovskaya"'
Autor:
G. R. Arakelyan, O. Yu. Yakimovich, Yu. P. Finashutina, NN Kasatkina, A. S. Antipova, Yu. E. Ryabukhina, V. A. Misyurin, H. S. Mkrtchyan, A. A. Semenova, A D Shirin, M. Yu. Kichigina, IZ Zavodnova, A. A. Solodovnik, O. M. Votyakova, O. A. Kolomeytsev, V. V. Tikhonova, A. V. Misyurin, O. N. Solopova, EG Medvedovskaya, EA Osmanov, O. M. Volodina
Publikováno v:
Uspehi Molekulârnoj Onkologii, Vol 5, Iss 2, Pp 62-70 (2018)
Objective:to study the prognostic significance of the expression of cancer-testis (CT) genes PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 in patients with multiple myeloma (MM) and their influence on overall survival and rela
Autor:
YuI Pryamikova, Gayane Tumyan, EA Osmanov, AA Leont’eva, LV Manzyuk, E A Demina, V. B. Larionova, O P Trofimova, NA Probatova, NV Kokosadze, V M Sotnikov, YuE Ryabukhina, NV Volkova, EV Paramonova, EG Medvedovskaya
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 443-452 (2017)
Aim. To assess the efficacy and toxicity of intensive 6 courses EACOPP-14 treatment with or without radiotherapy (RT) for advanced stages of Hodgkin's lymphoma (HL). Materials & Methods. From November 2009 to February 2015, 95 patients with advanced
Autor:
NV Kokosadze, V M Sotnikov, EV Paramonova, I. P. Aslanidi, E A Demina, V. B. Larionova, EG Medvedovskaya, AA Leont’eva, V.A. Manukova, Gayane Tumyan, YuE Ryabukhina, Mukhortova Ov, EA Osmanov, O P Trofimova, AYu Zaitseva, LV Manzyuk, LA Radkevich, Rudas
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 2, Pp 150-157 (2017)
Aim. To evaluate the relevance of the positron-emission therapy (PET) for optimization of the therapy of advanced Hodgkin's lymphoma (HL) using the intensive EACOPP-14 program. Materials & Methods. 91 patients with advanced HL (IIX-IIE, III-IV) recei
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 1, Pp 13-24 (2017)
Primary mediastinal (thymic) large B-cell lymphoma (PMB-CL) is one of the primary extranodal tumors and originates from thymic medulla B cells. The disease is more common in young women and declares itself by mainly locally advanced growth within the